Value20202021202220232024TTMSelling/general/admin expenses25.68 M29.66 M43.63 M69.14 M145.73 M160.96 MResearch & development51.49 M85.73 M95.52 M125.05 M103.74 M81.32 MOperating income76.91 M114 M138.55 M193.94 M173.73 M63.09 MNon-Operating Income, Total2 M1.63 M3.53 M18.18 M19.84 M19.58 MInterest expense, net of interest capitalized760 K3.74 M6.88 M8.31 M18.5 M34.07 MNon-Operating Income, excl. Interest Expenses1.07 M-3.21 M-4.35 M9.84 M1.1 M-14.84 MUnusual income/expense168 K1.1 M1 M23 K236 K353 KPretax income78.91 M115.63 M142.08 M212.12 M174.52 M207.01 MEquity in earnings——————Taxes-19.3 M-33.5 M-38.9 M-45.6 M449 K—Non-controlling/minority interest——————After tax other income/expense——————Net income before discontinued operations75.62 M116.11 M141.9 M184.13 M174.57 M79.99 MDiscontinued operations——————Net income75.62 M116.11 M141.9 M184.13 M174.57 M79.99 MDilution adjustment——————Preferred dividends——————Diluted net income available to common stockholders75.62 M116.11 M141.9 M184.13 M174.57 M79.99 MBasic earnings per share (Basic EPS)——-0.37-0.32-0.27-0.12Diluted earnings per share (Diluted EPS)——-0.37-0.32-0.27-0.12Average basic shares outstanding——380.78 M570.65 M646.03 M2.65 BDiluted shares outstanding——380.78 M570.65 M646.03 M2.65 BEBITDA——————EBIT——————Cost of revenue——————Other cost of goods sold——————Depreciation & amortization (cash flow)-481 K-531 K362 K-10.06 M-6.58 M-5.88 M
Geron Corporation
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase.